Update on the epidemiology of pulmonary nontuberculous mycobacterial infections

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 1, 2013, Pages 87-94

  Kendall, Brian A ^a,b   Winthrop, Kevin L ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

epidemiology; Mycobacterium avium; Mycobacterium tuberculosis; nontuberculous mycobacteria

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CORTICOSTEROID; INFLIXIMAB;

ARTICLE; ASIA; ASTHMA; ATYPICAL MYCOBACTERIOSIS; AUSTRALIA; BACTERIAL TRANSMISSION; BRONCHIECTASIS; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; ENVIRONMENTAL FACTOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-9; IMMUNOCOMPROMISED PATIENT; IRELAND; LUNG INFECTION; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PULMONARY NONTUBERCULOUS MYCOBACTERIAL INFECTION; RISK FACTOR; TAIWAN; TREND STUDY; UNITED KINGDOM; UNITED STATES; WATER SUPPLY;

HUMANS; LUNG DISEASES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; UNITED STATES; WORLD HEALTH;

EID: 84874397054     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1333567     Document Type: Article

References (62)

1. Aitken M. L., Limaye A., Pottinger P., et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med: 2012; 185 2 231 232
2. Feazel L. M., Baumgartner L. K., Peterson K. L., Frank D. N., Harris J. K., Pace N. R. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A: 2009; 106 38 16393 16399
3. O'Brien R. J., Geiter L. J., Snider D. E. Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis: 1987; 135 5 1007 1014 (Pubitemid 18021482)
4. Centers for Disease Control and Prevention (CDC) Trends in tuberculosis-United States, 2011. MMWR Morb Mortal Wkly Rep: 2012; 61 11 181 185
5. Ahn C. H., Lowell J. R., Onstad G. D., Shuford E. H., Hurst G. A. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest: 1979; 75 2 120 125 (Pubitemid 9128101)
6. Behr M. A. Mycobacterium du jour: what's on tomorrow's menu? Microbes Infect: 2008; 10 9 968 972
7. Fogan L. PPD antigens and the diagnosis of mycobacterial diseases. A study of atypical mycobacterial disease in Oklahoma. Arch Intern Med: 1969; 124 1 49 54
8. Griffith D. E., Aksamit T., Brown-Elliott B. A., et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med: 2007; 175 4 367 416
9. Winthrop K. L. Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view. Future Microbiol: 2010; 5 3 343 345
10. Marras T. K., Chedore P., Ying A. M., Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax: 2007; 62 8 661 666 (Pubitemid 47235003)
11. Hernandez-Garduno E., Rodrigues M., Elwood R. K. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis: 2009; 13 9 1086 1093
12. Cassidy P. M., Hedberg K., Saulson A., McNelly E., Winthrop K. L. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis: 2009; 49 12 e124 e129
13. Winthrop K. L., McNelley E., Kendall B., et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med: 2010; 182 7 977 982
14. Prevots D. R., Shaw P. A., Strickland D., et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med: 2010; 182 7 970 976
15. Adjemian J., Olivier K. N., Seitz A. E., Holland S. M., Prevots D. R. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med: 2012; 185 8 881 886
16. Billinger M. E., Olivier K. N., Viboud C., et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis: 2009; 15 10 1562 1569
17. Winthrop K. L., Baxter R., Liu L., et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf: 2011; 20 3 229 235
18. Kendall B. A., Varley C. D., Choi D., et al. Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis: 2011; 17 3 506 509
19. Satyanarayana G., Heysell S. K., Scully K. W., Houpt E. R. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis: 2011; 11 113
20. Simmon K. E., Brown-Elliott B. A., Ridge P. G., et al. Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA. Emerg Infect Dis: 2011; 17 9 1692 1700
21. Brown-Elliott B. A., Wallace R. J. Jr, Tichindelean C., et al. Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol: 2011; 49 12 4231 4238
22. Simons S., van Ingen J., Hsueh P. R., et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis: 2011; 17 3 343 349
23. Thomson R. M. NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis: 2010; 16 10 1576 1583
24. Lai C. C., Tan C. K., Chou C. H., et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis: 2010; 16 2 294 296
25. Lai C. C., Tan C. K., Lin S. H., et al. Clinical significance of nontuberculous mycobacteria isolates in elderly Taiwanese patients. Eur J Clin Microbiol Infect Dis: 2011; 30 6 779 783
26. Shen M. C., Lee S. S., Huang T. S., Liu Y. C. Clinical significance of isolation of Mycobacterium avium complex from respiratory specimens. J Formos Med Assoc: 2010; 109 7 517 523
27. Park Y. S., Lee C. H., Lee S. M., et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis: 2010; 14 8 1069 1071
28. Shojaei H., Heidarieh P., Hashemi A., Feizabadi M. M., Daei Naser A. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis: 2011; 64 4 265 271
29. Khanum T., Rasool S. A., Ajaz M., Khan A. I. Isolation-drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria. Pak J Pharm Sci: 2011; 24 4 527 532
30. Shenai S., Rodrigues C., Mehta A. Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis: 2010; 14 8 1001 1008
31. Moore J. E., Kruijshaar M. E., Ormerod L. P., Drobniewski F., Abubakar I. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health: 2010; 10 612
32. van Ingen J., Hoefsloot W., Dekhuijzen P. N., Boeree M. J., van Soolingen D. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis: 2010; 14 9 1176 1180
33. Gitti Z., Mantadakis E., Maraki S., Samonis G. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Future Microbiol: 2011; 6 9 1099 1109
34. Del Giudice G., Iadevaia C., Santoro G., Moscariello E., Smeraglia R., Marzo C. Nontuberculous mycobacterial lung disease in patients without HIV infection: a retrospective analysis over 3 years. Clin Respir J: 2011; 5 4 203 210
35. Bicmen C., Coskun M., Gunduz A. T., Senol G., Cirak A. K., Tibet G. Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? New Microbiol: 2010; 33 4 399 403
36. Amorim A., Macedo R., Lopes A., Rodrigues I., Pereira E. Non-tuberculous mycobacteria in HIV-negative patients with pulmonary disease in Lisbon, Portugal. Scand J Infect Dis: 2010; 42 8 626 628
37. Marusić A., Katalinić-Janković V., Popović-Grle S., et al. Mycobacterium xenopi pulmonary disease-epidemiology and clinical features in non-immunocompromised patients. J Infect: 2009; 58 2 108 112
38. van Ingen J., Boeree M. J., de Lange W. C., et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis: 2008; 14 3 385 389 (Pubitemid 351451384)
39. Andréjak C., Lescure F. X., Pukenyte E., et al. Xenopi Group Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax: 2009; 64 4 291 296
40. Hoefsloot W., van Ingen J., de Lange W. C., Dekhuijzen P. N., Boeree M. J., van Soolingen D. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J: 2009; 34 4 926 931
41. Falkinham J. O. III, Norton C. D., LeChevallier M. W. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol: 2001; 67 3 1225 1231 (Pubitemid 33643564)
42. Falkinham J. O. III. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis: 2011; 17 3 419 424
43. Winthrop K. L., Varley C. D., Ory J., Cassidy P. M., Hedberg K. Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA. Emerg Infect Dis: 2011; 17 9 1760 1761
44. Martin E. C., Parker B. C., Falkinham J. O. III. Epidemiology of infection by nontuberculous mycobacteria, VII: Absence of mycobacteria in southeastern groundwaters. Am Rev Respir Dis: 1987; 136 2 344 348 (Pubitemid 18018531)
45. Maekawa K., Ito Y., Hirai T., et al. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest: 2011; 140 3 723 729
46. Olivier K. N., Weber D. J., Wallace R. J. Jr., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Nontuberculous mycobacteria, I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med: 2003; 167 6 828 834 (Pubitemid 36801769)
47. Karakousis P. C., Moore R. D., Chaisson R. E. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis: 2004; 4 9 557 565 (Pubitemid 39141797)
48. Buijtels P. C., van der Sande M. A., Parkinson S., Verbrugh H. A., Petit P. L., van Soolingen D. Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study. Clin Microbiol Infect: 2010; 16 8 1142 1148
49. Buijtels P. C., van-der-Sande M. A., de-Graaff C. S., et al. Nontuberculous mycobacteria, zambia. Emerg Infect Dis: 2009; 15 2 242 249
50. Crump J. A., van Ingen J., Morrissey A. B., et al. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis: 2009; 15 1 53 55
51. McCarthy K. D., Cain K. P., Winthrop K. L., et al. Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Respir Crit Care Med: 2012; 185 9 981 988
52. Lai C. C., Tan C. K., Cheng A., et al. Nontuberculous mycobacterial infections in cancer patients in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis: 2012; 72 2 161 165
53. Wallis R. S., Broder M. S., Wong J. Y., Hanson M. E., Beenhouwer D. O. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis: 2004; 38 9 1261 1265 (Pubitemid 38608568)
54. Winthrop K. L., Chang E., Yamashita S., Iademarco M. F., LoBue P. A. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis: 2009; 15 10 1556 1561
55. Winthrop K., Baxter R., Liu L., et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis: 2013; 72 1 37 42
56. Hojo M., Iikura M., Hirano S., Sugiyama H., Kobayashi N., Kudo K. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Respirology: 2012; 17 1 185 190
57. Behr M. A., Falkinham J. O. III. Molecular epidemiology of nontuberculous mycobacteria. Future Microbiol: 2009; 4 8 1009 1020
58. Koh W. J., Jeon K., Lee N. Y., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med: 2011; 183 3 405 410
59. Pestel-Caron M., Arbeit R. D. Characterization of IS1245 for strain typing of Mycobacterium avium. J Clin Microbiol: 1998; 36 7 1859 1863 (Pubitemid 28277765)
60. Amonsin A., Li L. L., Zhang Q., et al. Multilocus short sequence repeat sequencing approach for differentiating among Mycobacterium avium subsp. paratuberculosis strains. J Clin Microbiol: 2004; 42 4 1694 1702 (Pubitemid 38500818)
61. Roux A. L., Catherinot E., Ripoll F., et al. Jean-Louis Herrmann for the OMA Group Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol: 2009; 47 12 4124 4128
62. Chen C. Y., Chen H. Y., Chou C. H., Huang C. T., Lai C. C., Hsueh P. R. Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis: 2012; 72 1 47 51